Richard Williams - Baker Hughes President North America Region
President
Mr. Richard L. Williams is President, North America Region of the Company. He served as President, U.S. Region from November 2012 to October 2013 and President, Gulf of Mexico Region from 2009 to 2012. Various executive positions within the Company from 1975 to 2009. Employed by the Company in 1975. since 2013.
Age | 49 |
Tenure | 11 years |
Phone | 713 439-8699 |
Web | www.bakerhughes.com |
Richard Williams Latest Insider Activity
Tracking and analyzing the buying and selling activities of Richard Williams against Baker Hughes stock is an integral part of due diligence when investing in Baker Hughes. Richard Williams insider activity provides valuable insight into whether Baker Hughes is net buyers or sellers over its current business cycle. Note, Baker Hughes insiders must abide by specific rules, including filing SEC forms every time they buy or sell Baker Hughes'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Richard Williams over three months ago Purchase by Richard Williams of 1000 shares of HomeTrust Bancshares | ||
Richard Williams over six months ago Purchase by Richard Williams of 1000 shares of HomeTrust Bancshares | ||
Richard Williams over six months ago Purchase by Richard Williams of 1000 shares of HomeTrust Bancshares | ||
Richard Williams over a year ago Acquisition by Richard Williams of 50000 shares of Adamis Pharma subject to Rule 16b-3 |
Baker Hughes Management Efficiency
Baker Hughes' management efficiency ratios could be used to measure how well Baker Hughes manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.02 B in debt with debt to equity (D/E) ratio of 24.0, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Baker Hughes has a current ratio of 4.13, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Baker Hughes until it has trouble settling it off, either with new capital or with free cash flow. So, Baker Hughes' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baker Hughes sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baker to invest in growth at high rates of return. When we think about Baker Hughes' use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | PRESIDENT Age | ||
Michael Harrington | Waters | 59 | |
Todd Skulte | RadNet Inc | 55 | |
Amol Chaubal | Waters | 47 | |
Elizabeth Rae | Waters | 60 | |
Jason Gottlieb | Artisan Partners Asset | 54 | |
Omkar Halady | Iris Acquisition Corp | 39 | |
Mital Patel | RadNet Inc | 38 | |
Derek Bomar | RadNet Inc | 46 | |
David Terricciano | Waters | 61 | |
Sherry Buck | Waters | 55 | |
Michael Murdock | RadNet Inc | 62 | |
John Crues | RadNet Inc | 67 | |
John Lynch | Waters | N/A | |
James Hamman | Artisan Partners Asset | 54 | |
Ian King | Waters | 63 | |
Robert Carson | Waters | 46 | |
Francis Kim | Waters | 51 | |
Dean Patenaude | Artisan Partners Asset | 52 | |
Eileen Kwei | Artisan Partners Asset | 45 | |
Terrance Kelly | Waters | 54 | |
Mark Beaudouin | Waters | 63 |
Management Performance
Return On Equity | -0.0022 | |||
Return On Asset | -0.0015 |
Baker Hughes Leadership Team
Elected by the shareholders, the Baker Hughes' board of directors comprises two types of representatives: Baker Hughes inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baker. The board's role is to monitor Baker Hughes' management team and ensure that shareholders' interests are well served. Baker Hughes' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baker Hughes' outside directors are responsible for providing unbiased perspectives on the board's policies.
Martin Craighead, Chairman, CEO and President and Chairman of Executive Committee | ||
Greg Brenneman, Independent Director | ||
Clarence Cazalot, Independent Director | ||
Lynn Elsenhans, Independent Director | ||
Lorenzo Tanada, Vice Chairman of the Board, Chief Compliance Officer | ||
Mauro Badiola, Chief Corporate Information Officer, Vice President - Finance | ||
Khaled Nouh, President Middle East and Asia Pacific Region | ||
Andrew Esparza, Chief Human Resource Officer | ||
Gregory Brenneman, Independent Director | ||
Anthony Fernandes, Independent Director | ||
Alan Keifer, Principal Accounting Officer, VP and Controller | ||
Richard Ward, President - Global Products and Services | ||
Larry Brady, Independent Director | ||
Trey Clark, Vice President - Investor Relations | ||
David Kho, Director | ||
Belgacem Chariag, Chief Integration Officer and VP | ||
William Marsh, Vice President General Counsel | ||
James Stewart, Independent Director | ||
Charles Watson, Independent Director | ||
James Williams, Senior Independent Director | ||
Claire Gargalli, Independent Director | ||
Derek Mathieson, Chief Technology and Marketing Officer and VP | ||
James Lash, Independent Director | ||
Klarence Dy, Director | ||
Arthur Soucy, President Europe, Africa and Russia Caspian Region | ||
Richard Williams, President North America Region | ||
Alfonzo Anggala, Director | ||
Pierre Jungels, Independent Director | ||
Jay Martin, Vice President Chief Compliance Officer, Senior Deputy General Counsel | ||
Ricardo Pascua, Independent Director | ||
Kelly Janzen, Chief Accounting Officer, Vice President Controller | ||
Alan Crain, Chief Legal and Governance Officer and Sr. VP | ||
Sham Daswani, Director | ||
Larry Nichols, Lead Independent Director | ||
Jim Baliad, Corporate Secretary | ||
William Easter, Independent Director | ||
Lyra LipaeFabella, Corporate Secretary, Alternate Corporate Information Officer | ||
Angela Durkin, Vice President - Health Safety & Environment. | ||
Archana Deskus, CIO, Vice President | ||
Michael Panlilio, Director | ||
Kimberly Ross, CFO and Sr. VP | ||
Victor Benavidez, Treasurer, Director | ||
Mario Ruscev, CTO, Vice President | ||
Andrew Watkins, Non-Executive Director | ||
Jose Panlilio, Chairman of the Board and Presidentident, CEO | ||
Christopher Gotanco, Director | ||
Reynaldo Maulit, Independent Director |
Baker Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Baker Hughes a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0022 | |||
Return On Asset | -0.0015 | |||
Profit Margin | (0) % | |||
Operating Margin | (9.53) % | |||
Current Valuation | 22.13 B | |||
Shares Outstanding | 425.48 M | |||
Shares Owned By Insiders | 5.53 % | |||
Shares Owned By Institutions | 85.10 % | |||
Number Of Shares Shorted | 13.67 M | |||
Price To Earning | (13.17) X |
Pair Trading with Baker Hughes
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baker Hughes position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baker Hughes will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Tenet Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tenet Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tenet Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tenet Healthcare to buy it.
The correlation of Tenet Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tenet Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tenet Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tenet Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Baker Hughes information on this page should be used as a complementary analysis to other Baker Hughes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Baker Stock
If you are still planning to invest in Baker Hughes check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Baker Hughes' history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |